Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Phylum Chlamydiae

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Infection

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypothesis: Ephrin-Eph Signaling Pathways Provide Novel Targets for Accelerated Re-Epithelialization of Cutaneous Wounds.

BioEssays : news and reviews in molecular, cellular and developmental biology·2025

Same author

<i>Chlamydia</i>-induced <i>ex vivo</i> activation of B cells from mice, nonhuman primates, and humans produces large numbers of uniformly activated antigen presenting cells.

bioRxiv : the preprint server for biology·2025

Same author

Exogenous ephrin-A3 reverses loss of vaginal epithelial barrier protection in progestin-treated mice.

Mucosal immunology·2025

Same author

Use of calibrated filter paper to evaluate vaginal moisture in mice.

Scientific reports·2025

Same author

Evaluating vaginal moisture in mice with calibrated filter paper.

Research square·2025

Same author

Ephrin-Eph signaling: an important regulator of epithelial integrity and barrier function.

Tissue barriers·2025

Search research articles

Related Experiment Video

Updated: May 26, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.

Jean M Chavez¹, Rodolfo D Vicetti Miguel, Thomas L Cherpes

¹Department of Pediatrics, University of Pittsburgh School of Medicine, Rangos Research Center, Room 9123, 4401 Penn Avenue, Pittsburgh, PA 15224, USA.

Infectious Diseases in Obstetrics and Gynecology

|December 7, 2011

Summary

This summary is machine-generated.

Chlamydia trachomatis control programs may increase infection susceptibility by reducing immune responses, despite lowering disease complications. This highlights challenges for developing effective chlamydia vaccines.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Related Experiment Videos

Last Updated: May 26, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

Forward Genetic Approaches in Chlamydia trachomatis

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

Published on: October 13, 2015

Area of Science:

Immunology
Epidemiology
Infectious Diseases

Background:

* Chlamydia trachomatis (C. trachomatis) infections are a major public health concern.
* Current control efforts focus on detection and treatment, aiming to reduce sequelae like pelvic inflammatory disease.
* Paradoxically, these efforts may impact population susceptibility and immune responses.

Purpose of the Study:

* To analyze the immunoepidemiological consequences of C. trachomatis control programs.
* To understand how infection control affects the development of protective immunity.
* To inform the design of prophylactic vaccines against C. trachomatis.

Main Methods:

* Review of findings from C. trachomatis infection control programs.
* Analysis of immunoepidemiological data related to chlamydial infections.
* Correlation of surveillance outcomes with immune response modulation.

Main Results:

* Enhanced detection and treatment of C. trachomatis may increase population susceptibility to infection.
* Control programs reduce adverse sequelae such as pelvic inflammatory disease and ectopic pregnancy.
* Eradication of C. trachomatis curtails pathogen-induced damage and abrogates protective immune responses.

Conclusions:

* C. trachomatis control strategies have complex immunoepidemiological effects.
* Reducing infection burden may inadvertently impair the development of natural immunity.
* Vaccine design must consider these immunoepidemiological factors for effective chlamydia prevention.